AMAS test, al jaren in Nederland beschikbaar. Artikel update 25 maart 2012
6 juni 2007: Voor de AMAS test hoeft u niet meer naar Amerika. Er is op dit moment nu ook in Nederland de mogelijkheid om de AMAS test uit te voeren, niet alleen voor borstkankerpatienten maar voor iedereen en alle kankerpatienten. Wel is de eis van de inspectie dat de AMAS test wordt uitgevoerd door een gekwalificeerd arts in combinatie met een consult. De kosten liggen dan ook wat hoger uiteraard dan alleen voor de AMAS test. Aan de andere kant is het adres waar dit wordt uitgevoerd een ons betrouwbaar en algemeen erkende artsenpraktijk waar ook gewerkt wordt met complementaire behandelwijzen. Stel dat de AMAS test een voor u slechte uitslag laat zien dan heeft u direct de mogelijkheid om met de arts een plan van aanpak te bespreken. Mail ons en we geven u het adres. De AMAS test is uitgevonden door Dr. Samuel Bogash en zijn vrouw Dr. Eleanor Bogash. Zij ontdekten tijdens onderzoekingen naar hersentumoren dat mensen met kanker wel bepaalde moleculen hadden en mensen zonder kanker niet of minder van die bepaalde moleculen. Dat bepaalde molecuul zou volgens dokter Bogash het immuunsysteem aanzetten om 'vreemde', dus ook kwaadaardige kankercellen, te vernietigen. In laboratoriumproeven toonde Dr. Bogash in 1988 al aan dat dit 'antigen' inderdaad kankercellen herkende en aanzet gaf tot vernietiging. Uit verdere onderzoeken is gebleken dat mensen met kanker een test resultaat hebben van AMAS boven de 135. en 'gezonde' mensen zonder kanker onder de 135. Uit dit alles is onderstaande procedure ontwikkeld door Dr. Bogash en erkent door de FDA in de USA.1. Vandaag de dag wordt een persoon die met klachten
komt die lijken op kanker uitgebreid onderzocht. Vaak wordt bloed afgenomen,
foto's gemaakt, CT-scan, uitstrijkje, mammografie enz. De AMAS test claimt dat
al deze onderzoeken niet nodig zijn als de AMAS test onder de 135 blijft. Pas
bij twijfel of duidelijk boven de 135 kunnen en moeten andere nadere onderzoeken
volgen.
2. Nadat een patiënt is
behandeld voor zijn kanker willen zowel arts als patiënt natuurlijk weten of er
nog kankercellen over zijn gebleven en hoe groot de kans is op een recidief. De
AMAS test kan daar antwoord op geven.. Als er nog kanker is overgebleven zal de
AMAS test in ieder geval hoger uitkomen dan 135. Is de test lager dan 135 dan
blijkt de kanker in 95% van de gevallen verdwenen. Wel moet de test regelmatig
worden herhaald.
3. Soms komt
het voor dat een schaduw op een foto of een plekje op lever of nieren verdacht
is. Meestal volgt dan een pijnlijke en vervelende bioptie of soms zelfs een
kijkoperatie. De AMAS test claimt dat dit niet nodig is en dat de test voldoende
antwoord geeft of de verdachte plek kwaadaardig is of niet. Als de AMAS test
normaal is is er ook geen sprake van kanker.
In een trial zijn 1000 vrouwen met borstkanker met de AMAS test gecontroleerd. Het bleek dat de AMAS test lang voor een uitstrijkje of mammografie dit aantoonde al kon tonen dat er geen sprake was van volledige genezing.
De AMAS test claimt alle voorkomende kankersoorten, waaronder ook de zeldzame soorten te ontdekken. Studies onder meer dan 6000 patiënten gaven een resultaat van hoger dan 95%. Een afwijking van 1% maakt dat de test voor 99% betrouwbaar is.
Voor de AMAS test hoef je nu niet meer naar Amerika,
maar is het mogelijk om de test samen met je arts/specialist te doen. Hoe en wat
is te lezen in de aanvullende informatie op de volgende sites:
Op deze site vind je info plus helemaal onderaan een bestelformulier:
http://www.amascancertest.com
Op deze site http://members.tripod.com/~AlexisRay/index.html
staat
onderstaand stukje tekst waar je kunt lezen hoe
het aan te pakken mocht je zo'n test willen doen:
CANCER
Early detection is allegedly the key factor in surviving
this disease. However, statistics published by associations such as the American
Cancer Society contradict this well-marketed advice: They state that 90% of all
cases of breast cancer as being "early detection." If that was true, and early
detection is the "key to survival," then why is it the second biggest killer
among women in nearly every age group? Clearly, the TREATMENT of breast cancer
needs to be considered a major factor in this mortality rate.
However, early, accurate detection
will enable us ALL to choose our
treatment methods with
greater variety of options. A blood test known as the Anti-Malignin Antibody in
Serum, (AMAS) test is the best diagnostic aid available for early, accurate
detection of cancer. A simple blood test, it can detect ALL types of cancer,
regardless of site or tissue type affected, even if the tumor is as small as a
pencil dot, up to three years before (traditional) clinical diagnosis or the
appearance of symptoms, with 95- to 99% accuracy. In 1977, the FDA permitted
marketing of this test, (under "Target Reagent" not AMAS.) Medicare and many
other insurance companies are paying for the test. It permits confirmation of
diagnosis while dramatically reducing or eliminating typical cancer-related
procedures, including: PSA's, mammograms, biopsies, x-rays, sonograms, and PAP
smears.
Use of this test will enable cancer survivors to
find peace of mind
concerning their status after
treatment and can reduce the need for harmful follow-up procedures such as
chemotherapy and radiation. It can also allow survivors to obtain health
insurance sooner than the typical 1- to 5 year waiting period.
The AMAS test is superior to all
aforementioned procedures because it
detects an
antibody, anti-malignin, present at the onset of cancer. Typical tests, like the
Prostate Specific Antigen, PSA, detect antigens, which are not present until a
tumor is large and in an advanced state! As for mammograms, their improved
ability to 'read' tissue masses has only produced more "uncertain diagnosis,"
which results in more procedures, such as the biopsy. Do the math: a biopsy
costs $1,500, the AMAS test: $135. Is it any wonder this test, which will
revolutionize the business of cancer, has been kept a secret??
The test was developed by Harvard
neurochemist Dr. Samuel Bogoch. His
lab, Oncolab, is the
only lab in the country offering an AMAS test. He has made it possible for you
to get the AMAS test anyway by obtaining a FREE AMAS test shipping kit:
1-800-9CA-TEST. It is required to do the AMAS test. The kit will arrive in
approximately 7-10 days. In it, clinical studies and data to support this
remarkable test. If you want to get an AMAS test, order the kit, THEN bring the
clinical data to your doctor. Chances are, s/he will not have heard of the test.
Do not be discouraged if they resist. Either persist, or find a new doctor to
approve of your local blood draw. (Even a chiropractor can approve a blood
draw!)
"A breakthrough in medical science...the AMAS test is a
repeatable,
highly accurate test for early detection and
monitoring of cancer."
Dr. Gordon Pedersen
PhD, Toxicology/Immunology
Program
Director
Inter-American Society of Chemotherapy
Finding a
lab:
This can be challenging
because about 1% of our population knows about
the AMAS
test. It is vital that you NOT ask the blood lab, "Do you do the AMAS test?"
Only Oncolab does the AMAS test. Instead, read the technician's instructions
found on the bottom of your doctor's authorization form, (in kit.) Fax a copy to
the local blood lab and ask if they will do the test according to those AMAS
test specifications.
Cancer
survivors should use the test quarterly until their antibody
levels have returned to normal. "High risk" individuals
also includes
smokers, those exposed to toxins, from
housekeepers to nuclear plant
workers, and,
surprisingly, the obese. Yes, obesity has been found to be a greater risk factor
for cancer than having a family history of cancer.
Objections:
Several doctors have asked me, "If this can detect a tumor
as small as
a pencil dot, how do we know where to treat
the tumor? How do we locate it?" Dr. Bogoch informed me that when the AMAS test
comes back elevated, a doctor and patient have a more serious 'chat' about the
patient's health. Often, they are able to pinpoint where other diagnostic tests
should be run.
A common
misconception is that we are "always" fighting cancer. This
theory has not been proven. Many people have a normal AMAS
test, disproving this theory. (A direct correlation between the presence of
cancer and the anti-malignin antibody has been established with 3,315
double-blind studies.)
If a small tumor has been
detected, you are urged to enhance your
immune system so
it can produce antibody needed to combat the disease. More on such products
later...
Voor verder informatie
kunt u contact opnemen met een Amerikaans laboratorium:
Oncolab
36 The Fenway
Boston, MA 02215
Tel = 800 922-
8378
Of kijken op deze twee sites:
Onderstaande is de Engelse versie van het Nederlandse bericht dat ik heb gemaakt over de AMAS test hierboven.
The AMAS Test (Anti-Malignin Antibody in Serum)
by Steven D. Edelston, M.D.
In 1974, Dr. Samuel Bogash (MD,
Ph.D.) discovered a new
antigen located on all cancer cells. He and his researcher / wife, Eleanor
Bogash, MD, founded Oncolab to do this test for research and later clinical
purposes.
Dr. Bogash is a
Harvard-trained research neurochemist. He discovered that the outer coating on
cancer cells contain sugar molecules over an inner layer of protein (glycoproteins). Cancer cells bump into each other and the outer layer is ground
off-exposing the inner protein layer and the malignin antigen.
It took Drs. Bogash seven years to determine that the
antigen was on all cancer cells, not just brain cancer which they were
originally studying.
Due to
cell recognition, our immune system spots Malignin. When it sees
this foreign protein it produces antibodies to destroy
it-Anti-malignin
antibodies. This is what is measured in
the study; it is our body's
defense against cancer. By
1988, Dr. Bogash showed that the anti-malignin antibody killed cancer cells in
the test tube.
Greater than 95%
of patients with cancer have AMAS levels above 135. AMAS levels below 135 are
seen in normal individuals who do not have cancer. Sometimes there is doubt
about the test (borderline numbers) and at these times the test needs to be
repeated and followed up at certain intervals.
Normal levels of AMAS are seen in successfully treated
cancer patients and in patients who never had cancer. Cases of advanced or
terminal cancer may also have normal levels or even very low normal. The
clinical status of the patient must be correlated with the AMAS test result.
The test is patented and the FDA has approved it. The test
is available
for use in several areas related to cancer:
1.Cancer Screening
Test. Today a check-up in your physician's office
includes a history, a physical examination and selected
laboratory tests aimed at detecting potential problems including cancer. It will
now include an AMAS test, and thus might defer using a chest X-ray,
proctoscope, CT scan, pap
smear, and even mammography.
These cancer
screens will not be needed unless the AMAS
test is abnormal.
2.A Cancer
Monitoring Test. After cancer has been treated both the patient and the doctor
want to know if the cancer has been cured or if some malignant cells are still
in the body. The AMAS test can answer this dilemma. If there is cancer present,
the AMAS test remains elevated.
3.In Differential Diagnosis. At times a shadow on a chest
X-ray or a spot in the liver or kidney on a CT scan are suspicious for cancer
and only a biopsy can tell. That is an invasive procedure. The AMAS test can
tell you if the tissue is malignant. If the AMAS is normal, the lesion in
question is not a cancer.
To
date, over 1000 patients with breast cancer have been studied using the AMAS
test. It has been used to tell if the cancer has been cured. New data suggests
that the breast cancer cannot be said to be in remission unless the AMAS test
returns to normal. AMAS has found breast cancer as small as a pencil dot long
before a mammogram can show it.
The AMAS detects all common cancers and the uncommon ones
too. Studies on more than 6000 patients show the sensitivity of AMAS to be
greater than 95%. The false positive rate and false negative rates are about 1%
of the total, making the specificity about 99%.
Contact info for those
interested:
Oncolab
36
The Fenway
Boston, MA 02215
Tel
= 800 922- 8378
